Type 1

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-09/trial-watch-dcb-tidepool-istock-961365406.jpg?itok=EZ2S0zL4

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-09/trial-watch-dcb-tidepool-istock-961365406.jpg?itok=a2FZCowf

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-09/trial-watch-dcb-tidepool-istock-961365406.jpg?itok=NC6MuEGe

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-09/trial-watch-dcb-tidepool-istock-961365406.jpg?itok=DJOlt42c

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-09/trial-watch-dcb-tidepool-istock-961365406.jpg?itok=oSZt-Udk

trial-watch-dcb-tidepool-istock-961365406.jpg

[node:summary] The Diabetes Center Berne and Tidepool Menstrual Cycle Study will collect data from women with type 1 diabetes to examine the relationship between periods and blood glucose levels.


New Study Examines the Impact of Periods on Type 1 Diabetes

Prediabetes

Type 2

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-05/zepbound_photo_lilly.jpeg?itok=4jrXuVVU

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-05/zepbound_photo_lilly.jpeg?itok=Hl93NQ52

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-05/zepbound_photo_lilly.jpeg?itok=-ze02kkD

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-05/zepbound_photo_lilly.jpeg?itok=N0rIvtpF

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-05/zepbound_photo_lilly.jpeg?itok=eig_Y7OU

zepbound_photo_lilly.jpeg

[node:summary] This clinical trial will evaluate the impact of tirzepatide (Zepbound) on kidney function in adults with or without type 2 diabetes living with kidney disease and excess weight or obesity. 


[node:title] | [site:name] TREASURE-CKD: New Trial Studying Tirzepatide for Chronic Kidney Disease

New Trial Studying Tirzepatide for Chronic Kidney Disease

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-08/trial-watch-nct-nct06238778-istock-1288871608.jpg?itok=WSwLMREJ

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-08/trial-watch-nct-nct06238778-istock-1288871608.jpg?itok=1MMo_njA

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-08/trial-watch-nct-nct06238778-istock-1288871608.jpg?itok=B5XDLMyP

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-08/trial-watch-nct-nct06238778-istock-1288871608.jpg?itok=mHbZ7So8

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-08/trial-watch-nct-nct06238778-istock-1288871608.jpg?itok=x0X99mSz

trial-watch-nct-nct06238778-istock-1288871608.jpg

[node:summary] Evaluate the impact of HDV-Lispro liver-targeted bolus insulin on hypoglycemia in adults 18-80 with type 1 diabetes. Join this Diasome Pharmaceuticals clinical trial.  


New Study Tests Liver-Targeted Insulin in Type 1 Diabetes

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-08/survodutidetrialwatch.jpg?itok=n5MLVsh_

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-08/survodutidetrialwatch.jpg?itok=TSrureru

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-08/survodutidetrialwatch.jpg?itok=63QsHqfR

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-08/survodutidetrialwatch.jpg?itok=eEp1R21_

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-08/survodutidetrialwatch.jpg?itok=fB8TU36E

survodutidetrialwatch.jpg

[node:summary] Join the SYNCHRONIZE™ - CVOT study (NCT06077864) by Boehringer Ingelheim to test the cardiovascular safety of survodutide in adults with overweight or obesity and weight-related health conditions.

Join a Trial Testing a New Medication for Obesity and Weight-Related Conditions

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-07/ozckd.png?itok=kYPz11QC

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-07/ozckd.png?itok=a48ZvWWF

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-07/ozckd.png?itok=KjX--iFU

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-07/ozckd.png?itok=cCZywLEP

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-07/ozckd.png?itok=B6xcPdyE

ozckd.png

Explore the impact of Ozempic (semaglutide) on kidney function in type 1 diabetes with chronic kidney disease. Join this University of Washington clinical trial.

New Trial Tests Ozempic For Kidney Disease in Type 1 Diabetes

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-07/unnamed-10.jpg?itok=E7IpWPHX

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-07/unnamed-10.jpg?itok=srvsEEhW

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-07/unnamed-10.jpg?itok=EguYeLoH

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-07/unnamed-10.jpg?itok=wGeWJ4SR

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-07/unnamed-10.jpg?itok=bySDjPTi

unnamed-10.jpg

Join a clinical trial testing cadisegliatin as adjunctive therapy in type 1 diabetes to test its effectiveness in reducing hypoglycemia. Open to those with type 1 diabetes in select U.S. states.

Join Trial Testing New Oral Medication for Type 1 Diabetes

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-07/petri-dish.jpg?itok=FQOzObeN

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-07/petri-dish.jpg?itok=MtJuf9wB

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-07/petri-dish.jpg?itok=3TzYcJ2Z

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-07/petri-dish.jpg?itok=pAeWHGa-

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-07/petri-dish.jpg?itok=KPOWDU_V

petri-dish.jpg

The VX-264 trial for people with type 1 diabetes looks to gauge the effectiveness of implanted islet cells, which control blood sugar levels. The  treatment uses an encapsulation device that protects the stem-cell derived cells from the body’s immune system.

Join Trial Testing Potential Cure for Type 1 Diabetes

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-06/pathwaypreventiontrialnet.jpg?itok=NNSkW3qr

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-06/pathwaypreventiontrialnet.jpg?itok=OE__Vr_P

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-06/pathwaypreventiontrialnet.jpg?itok=dM-FdukP

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-06/pathwaypreventiontrialnet.jpg?itok=gRT49cBd

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-06/pathwaypreventiontrialnet.jpg?itok=AReoWLt1

pathwaypreventiontrialnet.jpg

For relatives of people with type 1 diabetes (T1D), about 5% have certain antibodies associated with causing T1D. By joining this clinical trial, you or your relatives could contribute to the future of prevention and early treatment of T1D.

Have a Relative With Type 1 Diabetes? Join a Clinical Trial To Learn Your Risk

Gestational

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-07/gdm-updates-ada-2024-istock-1266654507.jpg?itok=iLNiYA_p

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-07/gdm-updates-ada-2024-istock-1266654507.jpg?itok=GeYxvyKA

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-07/gdm-updates-ada-2024-istock-1266654507.jpg?itok=2mWXdBNR

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-07/gdm-updates-ada-2024-istock-1266654507.jpg?itok=SRNIvMx-

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-07/gdm-updates-ada-2024-istock-1266654507.jpg?itok=BRByhlhk

gdm-updates-ada-2024-istock-1266654507.jpg

Gestational Diabetes: Latest Research Updates

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-06/screen-shot-2024-06-24-at-7.50.46-pm.png?itok=AK81CZlJ

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-06/screen-shot-2024-06-24-at-7.50.46-pm.png?itok=CxdKU1Nj

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-06/screen-shot-2024-06-24-at-7.50.46-pm.png?itok=Wr3qG_lu

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-06/screen-shot-2024-06-24-at-7.50.46-pm.png?itok=P60VX-F9

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-06/screen-shot-2024-06-24-at-7.50.46-pm.png?itok=TnxfBNTk

screen-shot-2024-06-24-at-7.50.46-pm.png

We’ve reviewed the latest research to weigh the benefits and drawbacks of intermittent fasting and time-restricted feeding for people with diabetes.

The latest research weighs the benefits and drawbacks of intermittent fasting for people with diabetes. Here’s a closer look at what this eating strategy entails and its promise for weight loss and blood sugar management. 

Does Intermittent Fasting Help People with Diabetes?

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-06/istock-1735113172.jpg?itok=wWMRMpFs

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-06/istock-1735113172.jpg?itok=2tDUs2ob

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-06/istock-1735113172.jpg?itok=MsP5z2_8

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-06/istock-1735113172.jpg?itok=ERHP4uHy

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-06/istock-1735113172.jpg?itok=oix_b-y2

istock-1735113172.jpg

Diabetes Technology on Display at ADA 2024

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-05/diabetes-stigma-2024-istock-1412852128.jpg?itok=OPcxewxU

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-05/diabetes-stigma-2024-istock-1412852128.jpg?itok=pSVs2LmF

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-05/diabetes-stigma-2024-istock-1412852128.jpg?itok=uqfJrJVv

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-05/diabetes-stigma-2024-istock-1412852128.jpg?itok=P4oJMbw8

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-05/diabetes-stigma-2024-istock-1412852128.jpg?itok=FcrYmFJ9

diabetes-stigma-2024-istock-1412852128.jpg

Diabetes Stigma: Let's Flip the Script

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-06/istock-1433066003.jpg?itok=eMn_j8_I

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-06/istock-1433066003.jpg?itok=lN0gl5yR

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-06/istock-1433066003.jpg?itok=Pp-AXXD6

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-06/istock-1433066003.jpg?itok=0ixZBZG5

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-06/istock-1433066003.jpg?itok=0gV4z2g-

istock-1433066003.jpg

Generic Victoza Now Available in the U.S.

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-06/screen-shot-2024-06-23-at-1.24.06-pm.png?itok=3sVei0Ot

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-06/screen-shot-2024-06-23-at-1.24.06-pm.png?itok=aI25y6_P

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-06/screen-shot-2024-06-23-at-1.24.06-pm.png?itok=0XzzHb7Q

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-06/screen-shot-2024-06-23-at-1.24.06-pm.png?itok=n3UsI8kG

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-06/screen-shot-2024-06-23-at-1.24.06-pm.png?itok=cednbZsS

screen-shot-2024-06-23-at-1.24.06-pm.png

Afrezza, an ultra rapid-acting inhaled insulin, offers an alternative to injections for mealtime glucose management. It starts working in 12 minutes and works well for some, but not for all people with diabetes. 

Afrezza Inhaled Insulin for Adults with Type 1 Diabetes: What Have We Learned? 

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-06/dr.-califf-3.jpg?itok=M6Dzz65X

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-06/dr.-califf-3.jpg?itok=o6kfN8Mi

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-06/dr.-califf-3.jpg?itok=mNkeY6nf

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-06/dr.-califf-3.jpg?itok=2fpi_oJ_

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-06/dr.-califf-3.jpg?itok=0Tnd0eVG

dr.-califf-3.jpg

Despite recent breakthroughs in diabetes treatments, FDA head Dr. Robert Califf in his keynote address urged greater attention to the rise of type 2 diabetes.

FDA Commissioner Says ‘We’re Failing’ People With Type 2 Diabetes

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-06/istock-1372020543.jpg?itok=L5an8F9I

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-06/istock-1372020543.jpg?itok=6IyoPOmq

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-06/istock-1372020543.jpg?itok=aqGec0c3

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-06/istock-1372020543.jpg?itok=NFmaW3UI

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-06/istock-1372020543.jpg?itok=W14Gh5mE

istock-1372020543.jpg

A cure has long been a pipe dream for the millions of people living with type 1 diabetes. New data from Vertex released at ADA 2024 on a revolutionary cell therapy suggests a significant step toward a cure.

A cure has long been a pipe dream for the millions of people living with type 1 diabetes. New data from Vertex released at ADA 2024 on a revolutionary cell therapy suggests a significant step toward a cure.

Vertex Releases New Data on Potential Cure for Type 1 Diabetes

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-09/istock-1552871673.jpg?itok=Esap_G1T

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-09/istock-1552871673.jpg?itok=2Lqk8MKr

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-09/istock-1552871673.jpg?itok=tEvSZU_J

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-09/istock-1552871673.jpg?itok=UVoG9V7L

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-09/istock-1552871673.jpg?itok=F_Diq6cb

istock-1552871673.jpg

Coffee is packed with all sorts of special compounds that could have benefits for health including weight loss – and maybe even diabetes prevention.


Can Coffee Help Prevent Diabetes?

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-06/lingo_0.png?itok=5xYvHSjc

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-06/lingo_0.png?itok=A7l39Pts

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-06/lingo_0.png?itok=wCfD164o

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-06/lingo_0.png?itok=g6coLJdl

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-06/lingo_0.png?itok=K3ORiaNp

lingo.png

FDA Clears Two New Abbott Over-the-Counter CGMs

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/2f9f3afb-d096-981b-8542-567bd871cfbd.png?itok=xEPYUca9

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/2f9f3afb-d096-981b-8542-567bd871cfbd.png?itok=XzIQUu4G

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/2f9f3afb-d096-981b-8542-567bd871cfbd.png?itok=S6CTzbDT

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/2f9f3afb-d096-981b-8542-567bd871cfbd.png?itok=Y7jkHvGp

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/2f9f3afb-d096-981b-8542-567bd871cfbd.png?itok=yeYI_gmF

Can a New Procedure Help People with Type 2 Diabetes on Insulin?

A new procedure called DMR (duodenal mucosal resurfacing) is being studied in clinical trials to see if it can help people with type 2 diabetes improve their A1C without the need for insulin.

A new intestinal procedure is being studied in clinical trials to see if it can help people with type 2 diabetes improve their A1C without the need for insulin. 

Can a New Procedure Help People with Type 2 Diabetes?

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-08/surmount-1-istock-1492726899.jpg?itok=Cmvczbvy

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-08/surmount-1-istock-1492726899.jpg?itok=GgCHxvsh

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-08/surmount-1-istock-1492726899.jpg?itok=Vh_1yA1Z

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-08/surmount-1-istock-1492726899.jpg?itok=XfCQx8Q6

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-08/surmount-1-istock-1492726899.jpg?itok=EaZ69sK1

surmount-1-istock-1492726899.jpg

[node:summary] SURMOUNT-1 clinical trial shows tirzepatide (marketed as Mounjaro, Zepbound) reduces the progression of prediabetes to type 2 diabetes by up to 94%.

Study: Tirzepatide (Zepbound) Cuts Prediabetes Progression to Type 2 by up to 94%

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-08/woman-sleeping-with-cgm.jpg?itok=O7bG2gf2

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-08/woman-sleeping-with-cgm.jpg?itok=0O_VVgao

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-08/woman-sleeping-with-cgm.jpg?itok=UkKeDMI-

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-08/woman-sleeping-with-cgm.jpg?itok=sfz45qJ6

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-08/woman-sleeping-with-cgm.jpg?itok=IDnqTk2N

woman-sleeping-with-cgm.jpg

]Turning lights and screens off before sleep could significantly reduce the chance of developing type 2 diabetes, research finds. 

Nighttime Light Exposure Increases Type 2 Diabetes Risk

New single-dose 2.5 mg ($400) and 5 mg ($550) vials of Tirzepatide will be soldsell directly on Eli Lilly's telehealth site.  

: Zepbound Price Cut in Half for Lowest Doses

Zepbound (Tirzepatide) for Chronic Weight Management: Uses, Side Effects, and Cost

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/ozempic.jpeg?itok=ikk_o-bT

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/ozempic.jpeg?itok=DyEeWrE5

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/ozempic.jpeg?itok=R9DCYHuS

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/ozempic.jpeg?itok=IoFnAbk7

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/ozempic.jpeg?itok=70cHw4fz

FDA Warns Against Compounded Semaglutide for Diabetes, Weight Loss

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-07/istock-1213293784.jpg?itok=M9bbtTmF

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-07/istock-1213293784.jpg?itok=iXTDjwF5

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-07/istock-1213293784.jpg?itok=tImvcPF4

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-07/istock-1213293784.jpg?itok=hTktswUL

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-07/istock-1213293784.jpg?itok=cTr99sCl

istock-1213293784.jpg

Novo Nordisk’s much-anticipated once-weekly insulin has been denied at this time by the U.S. Food and Drug Administration. The medication has been approved in Europe, Canada, Australia, Japan, and China. 

Once-Weekly Insulin Not Approved by FDA 

FDA Surprises Novo Nordisk by Not Approving Once-Weekly Insulin

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/twiist.png?itok=54yBhayV

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/twiist.png?itok=k4RbfCk-

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/twiist.png?itok=dLy1Fcc5

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/twiist.png?itok=1Gld5qKk

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/twiist.png?itok=Fvd6rpYc

FDA Clears twiist Automated Insulin Delivery System

The twiist AID system is the first insulin pump to integrate with Tidepool Loop. Approved for people with type 1 diabetes ages 6 and up, the twiist AID system with Tidepool Loop offers precise microdosing, the option to set a target as low as 87 mg/dL, and bolusing based on different food types.

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/rezdiffra.jpg?itok=sWwraUOE

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/rezdiffra.jpg?itok=aITg23PN

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/rezdiffra.jpg?itok=Quub0yTJ

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/rezdiffra.jpg?itok=FsxLkHoE

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/rezdiffra.jpg?itok=PCqdnGrp

Diabetes Research

Everything You Should Know About Clinical Trials

Why Should You Consider Participating in Diabetes Research?

Latest Stories About Open Clinical Trials

New Study Examines the Impact of Periods on Type 1 Diabetes

New Trial Studying Tirzepatide for Chronic Kidney Disease

New Study Tests Liver-Targeted Insulin in Type 1 Diabetes

Join a Trial Testing a New Medication for Obesity and Weight-Related Conditions

New Trial Tests Ozempic For Kidney Disease in Type 1 Diabetes

Join Trial Testing New Oral Medication for Type 1 Diabetes

Join Trial Testing Potential Cure for Type 1 Diabetes

Have a Relative With Type 1 Diabetes? Join a Clinical Trial To Learn Your Risk

Recent Research Findings

Can Coffee Help Prevent Diabetes?

FDA Clears Two New Abbott Over-the-Counter CGMs

New Study Examines the Impact of Periods on Type 1 Diabetes

Can a New Procedure Help People with Type 2 Diabetes?

Study: Tirzepatide (Zepbound) Cuts Prediabetes Progression to Type 2 by up to 94%

Nighttime Light Exposure Increases Type 2 Diabetes Risk

New Trial Studying Tirzepatide for Chronic Kidney Disease

New Study Tests Liver-Targeted Insulin in Type 1 Diabetes

Latest Stories From Diabetes Conferences

Gestational Diabetes: Latest Research Updates

Does Intermittent Fasting Help People with Diabetes?

Diabetes Technology on Display at ADA 2024

Diabetes Stigma: Let's Flip the Script

Generic Victoza Now Available in the U.S.

Afrezza Inhaled Insulin for Adults with Type 1 Diabetes: What Have We Learned?

FDA Commissioner Says ‘We’re Failing’ People With Type 2 Diabetes

Vertex Releases New Data on Potential Cure for Type 1 Diabetes

Latest Regulatory Clearances and Approvals

FDA Clears Two New Abbott Over-the-Counter CGMs

Zepbound (Tirzepatide) for Chronic Weight Management: Uses, Side Effects, and Cost

FDA Warns Against Compounded Semaglutide for Diabetes, Weight Loss

FDA Surprises Novo Nordisk by Not Approving Once-Weekly Insulin

FDA Clears twiist Automated Insulin Delivery System

FDA Approves Rezdiffra, the First Drug for Advanced Liver Disease

FDA Authorizes First Digital Therapy App for Type 2 Diabetes Management

FDA Approves Farxiga in US for Chronic Heart Failure